Effect of Chemically Modified Carbon-Coated Iron Nanoparticles on the Structure of Human Atherosclerotic Plaques Ex Vivo and on Adipose Tissue in Chronic Experiment In Vivo; International Journal of Molecular Sciences; Vol. 23, iss. 15

Bibliografiset tiedot
Parent link:International Journal of Molecular Sciences
Vol. 23, iss. 15.— 2022.— [8241, 12 p. ]
Yhteisötekijä: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий
Muut tekijät: Akhmedov Sh. Shamil, Afanasyev S. Sergey, Beshchasna N. Natalia, Trusova M. E. Marina Evgenievna, Stepanov I. Ivan, Rebenkova M. Mariya, Poletykina E. Ya. Ekaterina Yaroslavovna, Vecherskiy Yu. Yuri, Tverdokhlebov S. I. Sergei Ivanovich, Bolbasov E. N. Evgeny Nikolaevich, Balakin S. Sascha, Opitz J. Jorg, Yermakov A. Anatoly, Kozlov B. Boris
Yhteenveto:The high mortality rate caused by atherosclerosis makes it necessary to constantly search for new and better treatments. In previous reports, chemically modified carbon-coated iron nanoparticles (Fe@C NPs) have been demonstrated a high biocompatibility and promising anti-plaque properties. To further investigate these effects, the interaction of these nanoparticles with the adipose tissue of Wistar rats (in vivo) and human atherosclerotic plaques (ex vivo) was studied. For the in vivo study, cobalt–chromium (CoCr) alloy tubes, which are used for coronary stent manufacturing, were prepared with a coating of polylactic acid (PLA) which contained either modified or non-modified Fe@C NPs in a 5% by weight concentration. The tubes were implanted into an area of subcutaneous fat in Wistar rats, where changes in the histological structure and functional properties of the surrounding tissue were observed in the case of coatings modified with Fe@C NPs. For the ex vivo study, freshly explanted human atherosclerotic plaques were treated in the physiological solution with doses of modified Fe@C NPs, with mass equal to 5% or 25% relative to the plaques. This treatment resulted in the release of cholesterol-like compounds from the surface of the plaques into the solution, thus proving a pronounced destructive effect on the plaque structure. Chemically modified Fe@C NPs, when used as an anti-atherosclerosis agent, were able to activate the activity of macrophages, which could lead to the destruction of atherosclerotic plaques structures. These findings could prove the fabrication of next-generation vascular stents with built-in anti-atherosclerotic agents.
Kieli:englanti
Julkaistu: 2022
Aiheet:
Linkit:https://doi.org/10.3390/ijms23158241
Aineistotyyppi: Elektroninen Kirjan osa
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=669004

MARC

LEADER 00000naa0a2200000 4500
001 669004
005 20250924124907.0
035 |a (RuTPU)RU\TPU\network\40241 
035 |a RU\TPU\network\40024 
090 |a 669004 
100 |a 20230207d2022 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Effect of Chemically Modified Carbon-Coated Iron Nanoparticles on the Structure of Human Atherosclerotic Plaques Ex Vivo and on Adipose Tissue in Chronic Experiment In Vivo  |f Sh. Akhmedov, S. Afanasyev, N. Beshchasna [et al.] 
203 |a Text  |c electronic 
320 |a [References: 17 tit.] 
330 |a The high mortality rate caused by atherosclerosis makes it necessary to constantly search for new and better treatments. In previous reports, chemically modified carbon-coated iron nanoparticles (Fe@C NPs) have been demonstrated a high biocompatibility and promising anti-plaque properties. To further investigate these effects, the interaction of these nanoparticles with the adipose tissue of Wistar rats (in vivo) and human atherosclerotic plaques (ex vivo) was studied. For the in vivo study, cobalt–chromium (CoCr) alloy tubes, which are used for coronary stent manufacturing, were prepared with a coating of polylactic acid (PLA) which contained either modified or non-modified Fe@C NPs in a 5% by weight concentration. The tubes were implanted into an area of subcutaneous fat in Wistar rats, where changes in the histological structure and functional properties of the surrounding tissue were observed in the case of coatings modified with Fe@C NPs. For the ex vivo study, freshly explanted human atherosclerotic plaques were treated in the physiological solution with doses of modified Fe@C NPs, with mass equal to 5% or 25% relative to the plaques. This treatment resulted in the release of cholesterol-like compounds from the surface of the plaques into the solution, thus proving a pronounced destructive effect on the plaque structure. Chemically modified Fe@C NPs, when used as an anti-atherosclerosis agent, were able to activate the activity of macrophages, which could lead to the destruction of atherosclerotic plaques structures. These findings could prove the fabrication of next-generation vascular stents with built-in anti-atherosclerotic agents. 
461 |t International Journal of Molecular Sciences 
463 |t Vol. 23, iss. 15  |v [8241, 12 p. ]  |d 2022 
610 1 |a труды учёных ТПУ 
610 1 |a электронный ресурс 
610 1 |a atherosclerosis 
610 1 |a atherosclerotic plaque 
610 1 |a chemically modified carbon-coated iron nanoparticle 
610 1 |a reverse cholesterol transport 
610 1 |a macrophage 
610 1 |a coronary stent 
701 1 |a Akhmedov  |b Sh.  |g Shamil 
701 1 |a Afanasyev  |b S.  |g Sergey 
701 1 |a Beshchasna  |b N.  |g Natalia 
701 1 |a Trusova  |b M. E.  |c organic chemist  |c Associate professor of Tomsk Polytechnic University, Candidate of chemical sciences  |f 1982-  |g Marina Evgenievna  |3 (RuTPU)RU\TPU\pers\31823  |9 15918 
701 1 |a Stepanov  |b I.  |g Ivan 
701 1 |a Rebenkova  |b M.  |g Mariya 
701 1 |a Poletykina  |b E. Ya.  |c chemical technologist  |c research engineer at Tomsk Polytechnic University  |f 1998-  |g Ekaterina Yaroslavovna  |3 (RuTPU)RU\TPU\pers\47482 
701 1 |a Vecherskiy  |b Yu.  |g Yuri 
701 1 |a Tverdokhlebov  |b S. I.  |c physicist  |c Associate Professor of Tomsk Polytechnic University, Candidate of physical and mathematical science  |f 1961-  |g Sergei Ivanovich  |3 (RuTPU)RU\TPU\pers\30855 
701 1 |a Bolbasov  |b E. N.  |c physicist  |c Senior Researcher at Tomsk Polytechnic University, Candidate of Technical Sciences  |f 1981-  |g Evgeny Nikolaevich  |3 (RuTPU)RU\TPU\pers\30857  |9 15103 
701 1 |a Balakin  |b S.  |g Sascha 
701 1 |a Opitz  |b J.  |g Jorg 
701 1 |a Yermakov  |b A.  |g Anatoly 
701 1 |a Kozlov  |b B.  |g Boris 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537 
801 0 |a RU  |b 63413507  |c 20230207  |g RCR 
856 4 |u https://doi.org/10.3390/ijms23158241 
942 |c CF